Geneva, June 16 -- International Clinical Trials Registry received information related to the study (ACTRN12625000583448) titled 'Total Neoadjuvant Therapy for Organ Preservation in Early-Stage Low Rectal Cancer' on June 4.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Efficacy
Primary Sponsor: Royal Adelaide Hospital / Central Adelaide Local Health Network
Condition:
Rectal Cancer
Rectal Cancer
Cancer - Bowel - Back passage (rectum) or large bowel (colon)
Intervention:
This trial is an investigator-initiated, multicentre, single-arm phase II study. In this study, patients with early-stage (cT2-3, N0, M0) low ...